Last Updated on eMC 08-11-2016 View medicine  | Takeda UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 4 - how to report a side effect
  • Improved presentation of PIL
  • Removal of black triangle

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Reasons for adding or updating:

  • Correction of spelling/typing errors

Reasons for adding or updating:

  • Change to side-effects

Reasons for adding or updating:

  • Change to MA holder contact details

Reasons for adding or updating:

  • Correction of spelling/typing errors

Reasons for adding or updating:

  • New PIL for new product